Ann C. Merrifield's Insider Trades & SAST Disclosures
Ann C. Merrifield's most recent trade in Lyra Therapeutics Inc was a trade of 30,000 Stock Option done . Disclosure was reported to the exchange on June 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ann C. Merrifield.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyra Therapeutics Inc | C. Ann Merrifield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option | |
| Lyra Therapeutics Inc | C. Ann Merrifield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option | |
| InVivo Therapeutics Holdin... | C. Ann Merrifield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 4,200 | 4,200 | - | - | Stock Option (right to buy) | |
| Lyra Therapeutics Inc | C. Ann Merrifield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 7,250 | 7,250 | - | - | Stock Option | |
| Lyra Therapeutics Inc | C. Ann Merrifield | Director | Purchase of securities on an exchange or from another person at price $ 5.05 per share. | 10 Jun 2022 | 4,000 | 11,328 | - | 5.1 | 20,200 | Common Stock |
| Lyra Therapeutics Inc | C. Ann Merrifield | Director | Purchase of securities on an exchange or from another person at price $ 4.81 per share. | 13 May 2022 | 3,500 | 7,000 | - | 4.8 | 16,846 | Common Stock |
| Lyra Therapeutics Inc | C. Ann Merrifield | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 13 May 2022 | 328 | 7,328 | - | 5 | 1,640 | Common Stock |
| Lyra Therapeutics Inc | C. Ann Merrifield | Director | Purchase of securities on an exchange or from another person at price $ 8.97 per share. | 17 Jun 2021 | 3,500 | 3,500 | - | 9.0 | 31,395 | Common Stock |
| Lyra Therapeutics Inc | C. Ann Merrifield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,250 | 7,250 | - | - | Stock Option | |
| InVivo Therapeutics Holdin... | C. Ann Merrifield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2021 | 15,000 | 15,000 | - | - | Stock option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges